Human-sized Magnetic Particle Imaging for Brain Applications by Gräser, M. et al.
Human-sized Magnetic Particle Imaging for Brain
Applications
M. Graeser1,2, F. Thieben1,2, P. Szwargulski1,2, F. Werner1,2, N. Gdaniec1,2,
M. Boberg1,2, F. Griese1,2, M. Mo¨ddel1,2, P. Ludewig3, D. van de Ven4,
O. M. Weber5, O. Woywode6, B. Gleich7, T. Knopp1,2
1Section for Biomedical Imaging, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
2Institute for Biomedical Imaging, Hamburg University of Technology, Hamburg, Germany
3Department of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
4Sensing and Inspection Technologies GmbH, Huerth,Germany
5Philips GmbH Market DACH, Hamburg, Germany
6Imaging Components, Philips Medical Systems DMC GmbH, Hamburg, Germany
7Research Laboratories, Philips GmbH Innovative Technologies, Hamburg, Germany
October 19, 2018
Abstract
Determining the brain perfusion is an important task for the diagnosis and treatment of vas-
cular diseases such as occlusions and intracerebral haemorrhage. Even after successful diagnosis
and treatment, there is a high risk of restenosis or rebleeding such that patients need intense and
frequent attention in the days after treatment. Within this work, we will present a diagnostic
tomographic imager that allows access to brain perfusion information quantitatively in short
intervals. The imager is the first functional magnetic particle imaging device for brain imaging
on a human-scale. It is highly sensitive and allows the detection of an iron concentration of
14.7 ng ml−1 (263 pmol ml−1), which is the lowest iron concentration imaged by MPI so far. The
imager is self-shielded and can be used in unshielded environments such as intensive care units.
In combination with the low technical requirements this opens up a whole variety of possible
medical applications and would allow monitoring possibilities on the stroke and intensive care
units.
1 Introduction
Neurovascular diseases such as ischaemic stroke, intracranial haemorrhage (ICH), and traumatic
brain injury (TBI) are some of the most severe conditions requiring immediate medical attention
and diligent monitoring after treatment. With 17 million cases per year worldwide, stroke is the
second most common single cause of death (with approximately 5.3 million deaths, second only to
ischaemic heart disease) and one of the leading causes of disability [1]. Since about 2 million neurons
die every minute after acute stroke, time is a very critical factor for a successful treatment. In turn
the requirements for any diagnostic imaging technique are high. The method has to be fast, easily
accessible, and convenient to use.
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The common clinical imaging techniques used for the brain are computed tomography (CT)
and magnetic resonance imaging (MRI). Both techniques have their pros and cons. CT has a high
spatial resolution, but it exposes the patient to radiation and in turn should not be used for recurring
monitoring applications after stroke treatment. In addition, the usage of iodine based contrast agents
is a contraindication for patients with kidney disease. MRI mainly suffers from a limited accessibility
for intensive care unit (ICU) patients and relatively long examination times. As both techniques
require dedicated rooms, no modality is currently available for continuous monitoring of the brain
perfusion within the ICU. In consequence, this leads to a heavy workload of medical staff that has
to control the brain function by motor tests, paralysis checks and ocular reaction. Imaging of the
brain is currently only done in a 24 h interval or if a worsening of the patients status is observed.
However, if the patient is put in artificial coma and has to be ventilated, the transport is a complex
and risky process.
A very promising new method for brain imaging is magnetic particle imaging (MPI) that was
introduced in 2005 by Gleich and Weizenecker [2]. MPI uses an inhomogeneous magnetic field
(selection-field), a temporally varying magnetic field in the kHz-range (drive-field), and a homoge-
neous field (focus-field) to increase the spatial coverage. MPI is a tracer-based imaging method and
measures the concentration of super-paramagnetic iron-oxide (SPIO) nanoparticles. The particles
are usually administered intravenously and allows imaging of the vascular system and organ per-
fusion. Within a preclinical setting MPI has already proven to be very fast (with more than 46
volumes per second [3]), to provide good spatial resolution below one millimeter [2], to be highly
sensitive with a detection limit of about 5 ng of iron [4, 5] and allow for flexible coil designs [6].
Application-wise MPI has proven to be capable of detecting ischaemic stroke with high sensitiv-
ity and high temporal resolution in a mouse model [7]. It has also been shown to be suitable for
imaging gut bleeding [8], lung perfusion [9], labeled stem cells [10], cerebral aneurysms [11], cancer
[12], and cerebral blood volume [13]. In addition, MPI has been shown to be a very useful tool in
interventional applications [14, 15] where it can even be used for catheter steering [16].
The major barrier for the transition from a preclinical setting to clinical use and the application
of MPI on a human-scale has been the lack of an imaging device with sufficient bore size. Most
systems described so far in the published literature have a free bore diameter between 3 cm and 12 cm
[17] and thus can only accommodate mice and rats. A first attempt at constructing a human torso
imager was reported in [18]. The authors found that building a human-sized system with a target
resolution of 1 mm will be a challenging task, requiring sophisticated and expensive highest-end
hardware. One important challenge when upscaling small imaging systems to the human-scale is
the large increase of technical effort. I.e. systems featuring high gradient strength of 2 T m−1 µ0−1
require high current densities in the field generating coils. As a result such systems have high
electrical power dissipation, which needs an appropriate cooling system integrated into the building.
Due to these technical challenges, the proof that MPI is clinically useful and sensible is still pending.
Within this work, we took an alternative approach and constructed a human-sized MPI system
that has low technical requirements designed for flexible and fast deployment in the clinical environ-
ment. The system is tailored for brain applications and has a bore size of 19 cm to 25 cm fitting an
adult’s head. We kept the technical requirements as low as possible while still fulfilling the clinical
requirements for a monitoring device for cerebral diseases. The scanner allows a small footprint in
the ICU, which is necessary where already several life-supporting and monitoring devices are used.
The system can be mounted bedside within the stroke or intensive care unit and it can be used for
regular monitoring of the neurovascular status. Based on quantitative perfusion maps and objec-
tive criteria, time consuming and risky CT and MRI scans as well as patient transport efforts are
avoided, reducing the risk for patients and the workload for medical staff. The device is evaluated in
technical experiments, and the suitability for neuro-imaging is evaluated in static as well as dynamic
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experiments using clinically approved tracer concentrations.
2 Results
2.1 System Overview
An overview of the developed brain scanner is given in Fig. 1. It consists of a drive-field coil for signal
excitation in x-direction (caudal-cranial), a dynamic selection-field generator for spatial encoding,
and a robot system for slice selection. All components are designed in a way that no additional
cooling of the system or shielding of the room is required. For the application scenario of stroke and
cerebral hemorrhage detection a spatial resolution of about 1 cm would be sufficient. This allows
the system to be designed with an reduced gradient strength of 0.2 T m−1 µ0−1 in y-direction which
is about 10% of the gradient strength of preclinical systems [19]. As encoding scheme an field-free-
point (FFP) configuration is used. Thus, in x- and z-direction the gradient provides only half of the
strength in comparison to the y-direction.
The amplitude of the magnetic field generated by the drive-field coil is chosen to be 6 mTµ0
−1
which can be implemented without any form of active cooling. One potential risk of the drive-field
amplitude is the stimulation peripheral of nerves (PNS). According to [20, 21] the limit for torso
applications is about 3 mTµ0
−1. As the PNS limit scales linear with the cross section facing the
magnetic fields applying 6 mTµ0
−1 for head applications should be safe based on the sizes of an
average human.
Using a static selection-field, the drive-field would sample only a single line in x-direction. To
sample a 2D slice, we use a dynamic selection-field that moves the FFP slowly in y-direction with
a repetition time of 0.5 s. In combination with the drive-field the FFP moves along a Cartesian
sampling trajectory and covers an field-of-view (FOV) of about 100 mm× 140 mm in the horizontal
plane. For slice selection in z-direction, the selection-field coils are mounted on a soft-iron yoke that
can be mechanically rotated using a servo motor and additionally moved in x-direction using a linear
motor. An in-depth discussion on the hardware setup can be found in section 4.
2.2 Sensitivity Study
To determine the sensitivity of the imager we used a protocol developed in [4]. First, a dilution
series of the tracer Perimag (micromod) was prepared with 50 µl samples and varying iron mass
between 2µg and 512 µg. For each iron mass, the sample was moved to three different positions
within the field-of-view (FOV), so that a distinction could be made between the sample signal and
reconstruction artefacts. All images were recorded using a 2D imaging sequence. Results of the
sensitivity study are shown in Fig. 2. It was possible to detect the sample without artefacts starting
from 512µg down to 8µg. For 2 µg several artefacts appeared, but the movement from the upper
left to the lower right corner was still visible. For 1 µg (not shown) and the control measurement, no
moving sample could be observed. Therefore, the detection limit of the scanner is about 2µg iron.
To translate the iron mass into a concentration, we prepared a concentration series and used an
ellipsoid (half-axes 40 mm, 40 mm and 20 mm =ˆ 134 ml) filled with different SPIO concentrations.
The ellipsoid was filled with 1µg to 20 µg iron in 1 µg steps leading to concentrations varying between
7.94 ng ml−1 and 147 ng ml−1. To determine the sensitivity limit for the concentration series we used
the same experimental protocol as the iron mass study. As can be seen in Fig. 2, it was possible to
detect the sample for concentrations starting at 147 ng ml−1 down to 14.7 ng ml−1. For 7.94 ng ml−1
(not shown) and for the control experiment no movement of the sample could be detected. Thus,
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Figure 1: (top) Picture of the developed MPI head scanner. The system calibration robot is placed to
the left the imager. (bottom) Scanner concept. The central coil is used as a drive-field generator with
a frequency of 25.699 kHz and an amplitude of 6 mTµ0
−1. The cross section is formed by two half
circles connected by straight parts forming an ellipsoid-like shape. The selection-field coils are driven
by sinusoidal currents with opposite signs superimposed by an offset current. This generates an FFP
oscillating on the y-axis in-between the selection-field coils. The superposition of the drive-field and
the selection-field generates a Cartesian like FFP trajectory covering an FOV within the xy-plane
of 100 mm× 140 mm. The particle response is received by dedicated coils in x- and y-direction.
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Iron Mass Series
Positions 512 µg, 9.17 µmol 32 µg, 0.57 µmol
8 µg, 0.14 µmol 2 µg, 36 nmol control
Iron Concentration Series
147 ngml−1, 2.63 nmolml−1 14.7 ngml−1, 263 pmolml−1 control
Figure 2: Sensitivity of the system. 50µl samples of Perimag with varying dilutions are moved to
three positions on the FOV diagonal (upper 6 images). The sample is considered to be detected if
the movement of the sample correlates to the signal shift in the image. Below 2 µg this correlation
fails. The same procedure is done with an ellipsoid of 134 ml filled with different concentrations
(lower 3 images). At a concentration of 14.7 ng ml−1 (263 pmol ml−1) the position is still detectable
while it fails at concentrations below that value.
the detection limit in terms of concentration is about 14.7 ng ml−1 (263 pmol ml−1), which is the
lowest iron concentration imaged by MPI so far.
2.3 Spatial Resolution Study
The targeted image resolution of the system was designed to be better than 10 mm to provide
sufficient image quality for imaging brain perfusion. To study the spatial resolution a phantom was
designed carrying two sample chambers each filled with 250µl Perimag at a concentration of c(Fe)
= 8.5 mg ml−1. The distance between the two samples was then varied between 5 mm and 9.5 mm
for the x- and y-direction and between 24 mm and 40 mm for the z-direction (edge to edge). The
orientation of the two dots can be changed such that the resolution limit can be determined in all
directions. All images were recorded with 2D imaging sequences.
The reconstructed images as well as profiles through the sample position are shown in Fig. 3.
The two dots with a separation of 9.5 mm could be resolved in the x- and the y-direction. The
signal intensity between the samples increased with decreasing distance, but a local minimum could
be observed in the profiles for both directions for a distance of 6 mm. The 5 mm distance could
still be resolved in x-direction, while it failed to be resolved in y-direction. In the z-direction the
resolution is less. A local minimum can be found at 26 mm while a separation fails at 24 mm. The
lower resolution can be explained by the lower gradient as well as the missing excitation and receive
5
9.5 mm 6.0 mm 5.0 mm
(a) Sample position along x-direction
9.5 mm 6.0 mm 5.0 mm
(b) Sample position along y-direction
40 mm 30 mm 26 mm 24 mm
(c) Sample position along z-direction
Figure 3: Spatial resolution of the developed MPI brain scanner. Two samples of 250µl Perimag
with a concentration of 8.5 mg ml−1 were placed at varying distance along the x-, y- and z-direction.
The pixel spacing of the images is 5 mm and marks the lower boundary that can be reached. In
x-direction the samples can be separated even for a distance of 5 mm. In y-direction the samples
with 5 mm distance cannot be resolved such that the resolution limit in y-direction is 6 mm. In
z-direction the samples can be resolved until a distance of 26 mm.
chain in z-direction.
2.4 Volumetric Imaging Sequence
To image 3D objects the scanner can adjust the height of the sampling plane by moving the selection-
field coils up and down using a servo motor. To demonstrate this feature, we prepared a 3D phantom
consisting of three slices containing different letters. Each letter was built using glass capillaries with
an inner diameter of 1.3 mm filled with diluted Perimag (c(Fe) = 8.5 mg ml−1). The slice containing
the letter K is placed in the central plane of the imager. The letter U is placed 32 mm above, whereas
the letter E is placed 32 mm below the central imaging plane. The scanner needs approximately 0.5 s
to move to the yoke (depending on the moved distance). 13 slices were measured, with 3 frames per
position to avoid motion artefacts. Thus, the total measurement time for the three slices was 26 s.
Reconstruction results for three slices of the 3D phantom are shown in Fig. 4. In the images the
three letters in the different imaging planes can be identified.
2.5 Static Brain Experiment
One target application of the presented system is the detection of an ischaemic stroke, which can be
identified by a perfusion deficiency in the respective brain area. The stroke is caused by a blood clot
or a stenosis in a vessel blocking the blood flow, and causing an under-perfusion of the brain area
supplied by the blocked vessel. To prove that MPI is capable of imaging perfusion deficits, a brain
phantom was constructed consisting of a right hemisphere containing a volume of 490 ml. The left
hemisphere was build with a stroke-like geometry cut out of the phantom leaving a volume of 440 ml.
A fitting part of 42 ml was build which reflects a typical stroke in the MCA-territory [22]. The parts
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Figure 4: Reconstruction results of the 3D phantom. The space covered by the three letters is
9 cm× 9 cm for each layer. The distance between the individual layers was 32 mm. The letters
consist of capillaries with an inner diameter of 1.3 mm filled with Perimag with a concentration of
8.5 mg l−1. The reconstructed images show the three letters without interference of the other layers.
The total image acquisition time of the 13 slices was 26 s.
can be filled with varying iron concentrations simulating different grades of perfusion deficits. Both
volumes are separated by a total wall thickness of 3 mm. The two hemispheres were placed in the
scanner and filled with a concentration of 965 ng ml−1 (17.3 nmol/ml) Perimag (total iron mass of
938.8 µg). The stroke part was built four times each filled with a different concentration of 0 ng ml−1,
318.5 ng ml−1, 637 ng ml−1 and 965 ng ml−1 respectively. The experiments were performed using a
2D imaging sequence. The experiment is considered successful if the stroke region shows a lower
concentration than the control experiment, where we inserted the 965 ng ml−1 concentration.
The results of the static stroke experiments are shown in Fig. 5. For a full perfusion defect
(100 % reduction) one can identify the dark stroke area on the right side of the image, which has a
triangular shape when considering the transversal cross-section through the phantom. Even in the
case of a 66 % reduction one can see that the particle concentration is lower in the stroke area. For
the 33 % reduction, the result is less clear. However, in comparison with the control measurement,
concentration differences can still be observed in the stroke area.
Within a monitoring scenario aimed at identifying restenosis, a control image could be made
after treatment, when the patient does not suffer from an acute perfusion defect. Using these
control measurements, difference images after each monitoring scan can be calculated. The results
of this scenario are shown in Fig. 5 as well. In the difference images it is easier to see the lower
concentration, in this case as a white area. As the phantom was taken out of the scanner between
consecutive measurements the exact position of the phantom inside the bore differed slightly which
leads to subtraction artifacts within the difference images and at the edges of the phantom. This
would also happen in a real monitoring scenario when the patient moves the head. Using rigid image
registration algorithms, these motion artifacts can be reduced. In an acute case where no control
image is available, difference images of the two hemispheres can be calculated.
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Figure 5: (left) Reconstruction results for the static stroke experiment. In the control case both
hemispheres and the stroke part were filled with a constant iron concentration of 965 ng ml−1 with
a total amount of 938.8µg. For the other cases the iron concentration in the stroke parts was less,
which can be identified in the images as a lower particle concentration in all three cases. The stroke
parts can be seen in the picture next to the head. (center) The lower concentration in the stroke
area becomes even more prominent when subtracting the control image from the stroke images as
can be seen in the second column of the images. As reference a cut of the CAD model is drawn next
to the control image. (right) Photograph of the phantom mounted on a human head model.
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2.6 Dynamic Perfusion Experiment
To evaluate the performance of the scanner in a dynamic setting, we developed a perfusion phantom
and performed flow experiments with bolus injection. The flow phantom shown in Fig. 6 consists
of two 50 ml tubes filled with 1 mm glass spheres to simulate capillaries within the tissue. The
measured remaining fluid volume is 20 ml corresponding to a fill factor of 60%. Each tube represents
a hemisphere of a brain. Inside both tubes, a 3D printed part is inserted consisting of two hollow
rods, which are connected via tubes to a peristaltic pump delivering an average flow of 100 ml min−1.
The two rods each have a line of evenly distributed holes facing in opposite directions towards the
outside of the tube. In this way, the entire length of the tube is perfused homogeneously whereas it
is expected that the flow exits the lumen facing towards the center of the phantom. It then passes
the glass spheres on its way to the outer side of the phantom and enters the second rod before
leaving the phantom towards the pump (see Fig. 6 top right). Four experiments were performed
using a 2D imaging sequence, each time injecting a volume of 100 µl as fast as possible: two times
with a concentration of c(Fe) = 8.5 mg ml−1 (150 µmol ml−1) and two times with a concentration
of c(Fe) = 0.85 mg ml−1 (15µmol ml−1) which corresponds to a total iron mass of 850 µg and 85µg
respectively. The bolus was injected at a distance of approximately 1.2 m allowing a dilution on the
way to the phantom similar to the dilution within a patient. For both concentrations two different
setups were examined. In one case the delivering hoses remained untouched, simulating a healthy
brain. In the other case, the hose of the left hemisphere was pinched off, simulating a stroke.
The results of the dynamic perfusion experiment are summarized in Fig. 6. Shown are three
selected time points where the bolus passed through the perfusion phantom. For both concentrations
the two hemispheres could be identified and spatially resolved. The scanning sequence is also fast
enough to track the inflow and the outflow of the tracer material. The images for the 850 µg bolus
had a slightly better spatial resolution than the images for the 85 µg bolus. The time data of four
selected points are shown in the graphs on top of the Fig. 6. The temporal characteristics are further
summarized in the pixel-wise calculated parameter maps (time-to-peak (TTP), mean-transit-time
(MTT), cerebral-blood-flow (rCBF) and cerebral-blood-volume (rCBF)). In the TTP map the lowest
values were present in the feeding hose, followed by the rods, the tubes, and the discharge hose. The
transit times were summarized in the MTT maps indicating lower values for the inner part of the
tubes compared to the outer part. The flow summarized in the rCBF maps was higher in the inner
part compared to the outer parts. The integrated particle concentration over time is shown in the
rCBV maps.
3 Discussion
Within this work, we built the first human-scale magnetic particle imaging system tailored for
cerebral imaging. The system has a high temporal resolution of 2 frames/s and can image down
to an iron mass of 2µg or an iron concentration of 14.7 ng ml−1 (263 pmol ml−1). At higher iron
concentrations, the spatial resolution is in the order of 6 mm within the xy-plane and 28 mm in the
z-direction. Due to its small size and the lack of requirements for building facilities, the system can
be realized mobile. This allows the diagnosis at the patient’s bed instead of bringing the patient to
the system.
In practice, it is not possible to obtain the best values for spatial resolution, temporal resolution,
sensitivity, and spatial coverage at the same time. In particular, for low iron concentrations, the
spatial resolution will be lower as has been shown in Fig. 2. To evaluate the scanner performance
in a more realistic setting, we performed experiments with two different kinds of brain phantoms.
The first had an anatomic shape and simulated different degrees of perfusion deficits. The second
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Figure 6: Dynamic imaging capabilities of the brain imager. The complete phantom can be seen
in the picture on the right. It consists of two 50 ml tubes filled with glass spheres. To visualize
the flow that is expected from the phantom a cross section sketch of the tubes is shown above the
image. The flow enters the tubes and is evenly distributed via perforated rods inside. The flow
exits the rods facing towards the center of the phantom and enters the drain rod facing the outer
side of the phantom. In the control experiment the hoses remain untouched while in the stenosis
setting the left inflow was pinched. The reconstructed images can be seen in gray scale on the left
side. At the lower dosage of 85µg iron both tubes were imaged and a stroke setting was detected.
With the higher dosage of 850 µg iron the spatial resolution improved and the inflow and outflow
became visible. For the control setting of the experiments with higher concentration, four regions
with characteristic temporal behavior were selected and their temporal progression is shown in the
graphs (top). The corresponding positions are marked in the reconstructed images of the high dose
control experiment. The signal was first detected in the feeding hose (red) with a lower duration
compared to the perforated hollow rods (blue). With a slightly higher temporal delay the signal
increased in the tubes (green) and the discharge hose (orange). As the bolus diluted while passing
through the phantom, the shape broadens and the signal duration was prolonged. From this time
data, the time-to-peak (TTP), mean-transit-time (MTT), relative cerebral-blood-flow (rCBF), and
relative cerebral-blood-volume (rCBV) perfusion maps were calculated. The rCBF and rCBV were
normalized to the maximum value in the imaging volume. All time data were normalized to the
arrival of the bolus.
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was a dynamic flow phantom and demonstrated the capability of the system of resolving dynamic
concentration changes. The results show that the scanner is capable of detecting a 42 ml stroke
even if the perfusion is reduced by only 33.3 %. The dynamic experiments show that it is possible
to derive brain perfusion parameter like TTP, MTT, rCBV, and rCBF, which are all very useful
for the diagnosis of different brain diseases. One limitation of the dynamic phantom was the flow
(100 ml min−1) which was lower than the typical cerebral blood flow (750 ml min−1). Nevertheless,
the resulting transit times between 10 s and 30 s are only slightly above the typical cerebral transit
times which are below 7 s [23] for healthy brain areas and above 7 s for stroke brain areas. We would
like to point out that the scanner itself with a frame rate of 2 frames/s would be capable of resolving
faster blood flow.
The main use case of the MPI scanner presented here is the monitoring of cerebral perfusion
within the stroke and intensive care unit. The device could address two different application scenar-
ios. First, the monitoring of treated stroke patients who have a high risk of restenosis, and second,
the monitoring of treated hemorrhage patients that have the risk of a rebleed. In both cases, one
has to develop a suitable clinical protocol to ensure a regular tracking of the patient’s health. The
scanner itself has no limitations in application time since it is free of ionizing radiation. However,
the tracer material is, of course, limited in its dose that may safely be administered. The approved
tracer dose for a 70 kg human for different SPIOs varies between 36 mg (Resovist) and 510 mg (Fer-
aheme) [24, 25], and depends on the application the tracer is designed for. These amounts of iron
must be compared to about 4− 5 g of iron that are typically administered within the human body.
In the following we will consider a dose limitation of 200 mg. To ensure longtime monitoring, the
blood circulation time of the particles is an important factor. Dextran-coated tracers like Resovist
usually have a short circulation time below 5 min and accumulate in the liver [26]. Using such a
tracer for monitoring would require regularly applying a small bolus. Compared to a single-shot
injection of 200 mg, the amount of iron in each injection would need to be much smaller, such that
the total dosage applied over the course of the monitoring period remains constant. Considering a
scenario with a bolus being injected every hour within 72 hours, the iron mass needs to be lowered
to 2.8 mg. Since the blood volume delivered to the brain is approximately 15 % of the total cardiac
output, a mass of 420 µg iron would pass through the brain per injection. This is only a factor of 2.2
below the 938.8 µg iron used in our static phantom experiments and a factor of 5 above the 85µg
iron applied in the dynamic phantom experiments. Thus, we can conclude that our scanner would
already address this clinical scenario and allow the measurement of brain perfusion parameter maps
over a time frame of 72 h. Using long circulating tracers [27] or encapsulation of the tracer into red
blood [28], it might be either possible to reduce the number of tracer applications or to reduce the
amount of tracer that is applied each time.
The next step needs to be the evaluation of the system on living subjects. Prior to this evaluation
various safety aspects of the system need to be tested. There are two important risks that need to
be addressed. The first is the risk of electric breakdowns into the subject which can be handled by
proper isolation of the drive-field and receive coils. The second risk is the potential of neural nerve
stimulation. While we estimated 6 mTµ0
−1 drive-field amplitude to be safe in human subjects,
nerve stimulation studies will be necessary to find out the actual nerve stimulation threshold for the
head. Concerning clinical application the level of disturbing signals coupling into the receive coils
from external electronic systems such as other patient monitoring systems needs to be investigated.
However the system demonstrated to work in unshielded enviroments.
The scanner characteristic is already sufficient to address the requirements of the clinical applica-
tion. Nevertheless, there is still potential for further improvement. One key improvement will be the
introduction of a second drive-field coil with field generation in z-direction. With that it will be pos-
sible to substantially improve the temporal resolution for 3D imaging in the order of 2 frames/s for
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a volumetric image of about 10 cm× 14 cm× 10 cm. The second drive-field channel combined with
a third receive channel in z-direction will furthermore substantially improve the spatial resolution
in z-direction. It is expected to be in the same range as the spatial resolution in x-direction.
For even longer surveillance times beyond 72 h or higher resolved images, the sensitivity of the
system needs to be improved further. Based on experiments and scaling factors derived in [4] an
optimization of the receive coil noise, filter characteristic and the low-noise-amplifier matching should
result in a signal-to-noise gain of about a factor of ten. Another factor between two and three can
be gained by using better tracer material [29]. Thus, in total a factor 20–30 could be reached. This
would not only lower the detection limit, but in general also improve the spatial resolution for low
tracer dosages.
Due to the small footprint and the very small power consumption, the scanner could be integrated
into emergency vehicles. This would allow pre-hospital diagnosis and in turn enables more specific
diagnostic procedures and faster treatment. For this scenario, the framerate of the scanner should
be improved to make the system more robust against motion artifacts. As the repetition time of
the system is currently limited by the dynamic selection field, low inductive coil designs need to be
investigated to increase the possible selection-field slew rate.
4 Methods
4.1 Drive-Field
The drive-field generator has a single channel that is directed in x-direction (caudal-cranial). The
solenoid-like drive-field coil is made of high frequency litz wire with 1000 strands of 100µm. The
cross section consists of two half circles connected by straight parts resulting in open distances
of 190 mm and 230 mm in y- and z-direction respectively, such that a human head fits into the
coil. The power dissipation of the coil is 66 W for generating 6 mTµ0
−1 along the x-direction. It
does not need additional cooling to thermal convection during measurements. The coil is driven
by a power amplifier (AETechron 2105) via a 5th order resonant band-pass filter and a capacitive
impedance matching. The drive-field amplitude is controlled using an inductive feedback to the
signal generator. The frequency of the drive-field is chosen to be 1.953 125 MHz / 76 ≈ 25.699 kHz
resulting in a drive-field period length of 38.912 µs.
4.2 Dynamic Selection-Field
To generate the selection-field electromagnetically without cooling, two coils in a Maxwell arrange-
ment are wound around a soft iron yoke that amplifies the magnetic field, provides thermal capac-
itance and serves as structural support. The coils consist of two copper bands wound around the
yoke fixed with epoxy resin. The distance between the coils is 300 mm. The coil has 648 turns
resulting in an inductance of 200 mH and a resistance of 1.8 Ω. Each coil is fed by a programmable
current source (SM-1500, Delta Electronica). The currents in the coils can be adjusted individually
such that an FFP can be generated at various positions along the y-axis by varying the current on
both coils. When moving the FFP along a line of 14 cm each coil has a mean power loss of 174 W.
Details on the applied imaging sequence are outlined in section 4.3.
4.3 Imaging Sequence
The superposition of the drive and the selection-field leads to an FFP oscillating along a line in
x-direction. The particle response has a unique amplitude and phase spectrum in each position
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along this sampling line since the selection-field provides a unique offset at each point. With a static
selection-field and a 1D excitation one could just measure the 1D particle distribution along the
sampling line. In order to cover a 2D slice, we apply sinusoidal shaped currents with a frequency
of 2 Hz on each selection-field coil. The phase difference between both fields is pi such that one coil
generates maximum field while the opposing coil generates minimum field. This changing relation
of the currents shifts the FFP towards the coil carrying the lower current. In combination with the
drive-field the FFP travels along a Cartesian like trajectory [30, 31]. The size of the trajectory is
about 10 cm in x-direction and about 14 cm in y-direction. Due to field imperfections, the gradient
strength within the FFP is not constant but varies between 0.164 T m−1 µ0−1 and 0.214 T m−1 µ0−1.
In total one selection-field cycle corresponds to 13000 drive-field cycles. For data reduction a block-
averaging with a factor of 100 is applied such that in total 130 line scans are available.
The yoke handling the selection-field coils is mounted on a linear axis and a servo motor which
can move the selection field generator in x- and z-direction. It can be used in two different ways.
Either it is used for slice selection in which case the imaging is performed in 2D with high temporal
resolution of 2 frames/s. Alternatively it can be used to form a 3D image by moving the slice up
and down and collecting individual slices. This is similar to MRI where volume images can be
measured slice by slice as well. For the volumetric measurements and the examination of the spatial
resolution in z direction, the yoke was moved from −30 mm until 30 mm in 5 mm steps. Within
60 mm a repositioning of the yoke in finished within 0.5 s. Thus the achievable time resolution of
the 3D volumetric images is dependent on the slice thickness of the sequence.
4.4 Receive Chain
When using a 1D excitation with only a collinear receive coil, the system would suffer from a very low
spatial resolution in the orthogonal directions caused by the 1D point spread function (PSF) being
sharper in the co-linear direction [32]. One way to improve the spatial resolution in the orthogonal
direction is to use a multi-dimensional receiver as proposed in [33]. In our system, the x receive coil
is realized as a gradiometer coil with 16 receive turns and 22 cancellation turns and which suppresses
background signals from the environment and the direct feed-through of the transmission chain [34].
The y-receive coil is realized in a non-gradiometric way, but it is decoupled from the drive-field
by orthogonality. The signal is fed to a custom JFET-based low noise amplifier. The amplified
signals are digitized with a custom data acquisition system (based on two RedPitaya boards) at a
sampling rate of 1.953 125 MS/s. The signals are transferred to the measurement PC using Ethernet
for storage and reconstruction. All MPI data measured with the system are stored in the magnetic
particle imaging data format (MDF) [35].
4.5 Tracer
All experiments were performed with Perimag (micromod, lot 05617 102-05), a commercially avail-
able tracer showing good signal performance similar to that of Resovist [36]. The latter has clinical
approval for liver diagnostic in some countries, but it has also been used for brain applications [37].
The undiluted iron concentration of the tracer was c(Fe) = 17 mg ml−1 (0.303 mmol ml−1).
4.6 System Calibration and Image Reconstruction
To reconstruct images from the measured raw data, prior knowledge of the system and particle
behavior is collected by measuring a system matrix [17]. A cubic delta sample (edge length 6.3 mm)
containing 250 µl Perimag (micromod, lot 05617 102-05) with an iron concentration of 17 mg ml−1
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(303.57 µmol ml−1) is moved on a 2D grid of size 28× 28 covering a FOV of 140 mm× 140 mm with
a robot while applying a full 2D imaging sequence at each position. The resulting data forms the
system matrix and contains the 1D system response for each position of the 2D grid and for each
of the 130 patches along the y-direction (see figure 1). The 2D system matrix is also used for those
experiments where the yoke was moved up and down. For the resolution analysis of the system in
z-direction we measured a second system matrix in the xz-plane having a grid of size 7× 17 covering
a FOV of 35 mm× 85 mm. Prior to reconstruction we performed background subtraction for both
the system matrix and the measured object measurement [38, 39]. Background data is measured
with an empty scanner bore.
For image reconstruction we use a joint approach [40] where the individual 1D measurements are
combined prior to reconstruction resulting in a single image for one cycle of the selection-field. The
linear imaging equation is solved iteratively with a regularized variant of the Kaczmarz algorithm.
The number of iterations is varied from 1 to 500 while the relative regularization parameter [41]
is chosen in the range of 0.1 to 100. Both parameters are selected based on the signal strength
of the raw data signal. For low signal strength a high regularization parameter and a low number
of iterations were used while the spatial resolution experiments having high signal strength were
reconstructed with a low regularization parameter and a high number of iterations.
The perfusion parameter maps were calculated as described in the following based on the low-
pass filtered pixel-wise concentration-time series. The time-to-peak values were extracted from the
series as the time of maximum concentration values. The MTT is the first moment of the time-
concentration series [42] divided by the integral of the time series, while the CBV is the integral
over time and the CBF is the maximum derivative of the concentration-time series. The CBV and
the CBF were normalized to the maximum value in the imaging volume, thus representing relative
values rCBV and rCBF.
5 Author Statements
MG, FT, PL, OWe, BG and TK contributed to critical discussions towards system design and
application scenarios. BG, OWo, OWe, and DvV contributed to the design of the dynamic selection
field generator. MG and FT designed and constructed the remaining MPI components. MB and MM
were modelling the selection fields as basis for sequence programming. TK designed and developed
the system software. PS and TK programmed the imaging sequences. FG programmed the robotic
devices. MG, FT, PS, FW, NG, and TK designed, planned and performed the imaging experiments.
MG and TK coordinated the project. MG, TK, NG and PS contributed writing the paper. All
authors reviewed the manuscript.
6 Acknowledgements
We thankfully acknowledges the financial support by the German Research Foundation (DFG, grant
number KN 1108/2-1) and the Federal Ministry of Education and Research (BMBF, grant numbers
05M16GKA, 13XP5060B). We thank MI Partners Eindhoven for technical assistance and the Insitute
for Robotics and Cognitive Systems Lu¨beck for 3D printing the coil frame. We would like to thank
Fiona Bailey for the linguistic correction of the article.
14
References
[1] Feigin, V. L. et al. Global and regional burden of stroke during 1990–2010: findings from the
global burden of disease study 2010. The Lancet 383, 245–255 (2014).
[2] Gleich, B. & Weizenecker, J. Tomographic imaging using the nonlinear response of magnetic
particles. Nature 435, 1214–1217 (2005).
[3] Weizenecker, J., Gleich, B., Rahmer, J., Dahnke, H. & Borgert, J. Three-dimensional real-time
in vivo magnetic particle imaging. Physics in Medicine and Biology 54, L1–L10 (2009).
[4] Graeser, M. et al. Towards picogram detection of superparamagnetic iron-oxide particles using
a gradiometric receive coil. Scientific reports 7, 6872 (2017).
[5] Zheng, B. et al. Magnetic particle imaging tracks the long-term fate of in vivo neural cell
implants with high image contrast. Scientific reports 5, 14055 (2015).
[6] Sattel, T. et al. Single-sided device for magnetic particle imaging. Journal of Physics D: Applied
Physics 42, 1–5 (2009).
[7] Ludewig, P. et al. Magnetic particle imaging for real-time perfusion imaging in acute stroke.
ACS nano 11, 10480–10488 (2017).
[8] Yu, E. Y. et al. Magnetic particle imaging for highly sensitive, quantitative, and safe in vivo
gut bleed detection in a murine model. ACS nano 11, 12067–12076 (2017).
[9] Zhou, X. Y. et al. First in vivo magnetic particle imaging of lung perfusion in rats. Physics in
Medicine & Biology 62, 3510 (2017).
[10] Bulte, J. W. et al. Quantitative “hot spot” imaging of transplanted stem cells using super-
paramagnetic tracers and magnetic particle imaging (mpi). Tomography: a journal for imaging
research 1, 91 (2015).
[11] Sedlacik, J. et al. Magnetic particle imaging for high temporal resolution assessment of aneurysm
hemodynamics. PloS one 11, e0160097 (2016).
[12] Arami, H. et al. Tomographic magnetic particle imaging of cancer targeted nanoparticles.
Nanoscale 9, 18723–18730 (2017).
[13] Cooley, C. Z., Mandeville, J. B., Mason, E. E., Mandeville, E. T. & Wald, L. L. Rodent cerebral
blood volume (cbv) changes during hypercapnia observed using magnetic particle imaging (mpi)
detection. NeuroImage (2018).
[14] Haegele, J. et al. Multi-color magnetic particle imaging for cardiovascular interventions. Physics
in Medicine and Biology 61, N415 (2016).
[15] Salamon, J. et al. Magnetic particle/magnetic resonance imaging: In-vitro mpi-guided real time
catheter tracking and 4d angioplasty using a road map and blood pool tracer approach. PloS
one 11, e0156899 (2016).
[16] Rahmer, J., Wirtz, D., Bontus, C., Borgert, J. & Gleich, B. Interactive magnetic catheter steer-
ing with 3-d real-time feedback using multi-color magnetic particle imaging. IEEE transactions
on medical imaging 36, 1449–1456 (2017).
15
[17] Knopp, T., Gdaniec, N. & Mo¨ddel, M. Magnetic particle imaging: From proof of principle to
preclinical applications. Physics in Medicine & Biology 62, R124 (2017).
[18] Rahmer, J., Stehning, C. & Gleich, B. Remote magnetic actuation using a clinical scale system.
PloS one 13, e0193546 (2018).
[19] Kaul, M. G. et al. Combined preclinical magnetic particle imaging and magnetic resonance
imaging: Initial results in mice. Ro¨Fo 187, 347–352 (2015).
[20] Schmale, I. et al. Human PNS and SAR study in the frequency range from 24 to 162 kHz. In
2013 International Workshop on Magnetic Particle Imaging (IWMPI), 1–1 (2013).
[21] Saritas, E., Goodwill, P., Zhang, G. & Conolly, S. Magnetostimulation limits in magnetic
particle imaging. IEEE Transactions on Medical Imaging 32, 1600–1610 (2013).
[22] Sperber, C. & Karnath, H.-O. Topography of acute stroke in a sample of 439 right brain
damaged patients. NeuroImage: Clinical 10, 124 – 128 (2016).
[23] Bristow, M. S. et al. Mr perfusion and diffusion in acute ischemic stroke: Human gray and white
matter have different thresholds for infarction. Journal of Cerebral Blood Flow & Metabolism
25, 1280–1287 (2005). PMID: 15889043, https://doi.org/10.1038/sj.jcbfm.9600135.
[24] Wang, Y.-X. J., Hussain, S. M. & Krestin, G. P. Superparamagnetic iron oxide contrast agents:
physicochemical characteristics and applications in mr imaging. European radiology 11, 2319–
2331 (2001).
[25] Christen, T. et al. High-resolution cerebral blood volume imaging in humans using the blood
pool contrast agent ferumoxytol. Magnetic resonance in medicine 70, 705–710 (2013).
[26] Haegele, J. et al. Magnetic particle imaging: kinetics of the intravascular signal in vivo. Inter-
national Journal of Nanomedicine 4203–4209 (2014).
[27] Khandhar, A. P. et al. Evaluation of peg-coated iron oxide nanoparticles as blood pool tracers
for preclinical magnetic particle imaging. Nanoscale (2016).
[28] Rahmer, J. et al. Nanoparticle encapsulation in red blood cells enables blood-pool magnetic
particle imaging hours after injection. Physics in Medicine and Biology 58, 3965 (2013).
[29] Kaul, M. G. et al. In vitro and in vivo comparison of a tailored magnetic particle imaging blood
pool tracer with resovist. Physics in medicine and biology 62, 3454 (2017).
[30] Knopp, T. et al. Trajectory analysis for magnetic particle imaging. Physics in Medicine and
Biology 54, 385–397 (2009).
[31] Werner, F., Gdaniec, N. & Knopp, T. First experimental comparison between the cartesian
and the lissajous trajectory for magnetic particle imaging. Physics in Medicine & Biology 62,
3407 (2017).
[32] Goodwill, P. & Conolly, S. Multi-dimensional x-space magnetic particle imaging. IEEE Trans-
actions on Medical Imaging 30, 1581–1590 (2011).
[33] Graeser, M., von Gladiss, A., Weber, M. & Buzug, T. M. Two dimensional magnetic particle
spectrometry. Physics in Medicine & Biology 62 (2017).
16
[34] Graeser, M., Knopp, T., Gru¨ttner, M., Sattel, T. F. & Buzug, T. M. Analog receive signal
processing for magnetic particle imaging. Medical physics 40, 042303 (2013).
[35] Knopp, T. et al. MDF: Magnetic particle imaging data format. arXiv preprint arXiv:1602.06072
(2016).
[36] Lawaczeck, R. et al. Magnetic iron oxide particles coated with carboxydextran for parenteral
administration and liver contrasting: pre-clinical profile of sh u555a. Acta Radiologica 38,
584–597 (1997).
[37] Reimer, P., Schuierer, G., Balzer, T. & Peters, P. E. Application of a superparamagnetic
iron oxide (resovis®) for mr imaging of human cerebral blood volume. Magnetic resonance in
medicine 34, 694–697 (1995).
[38] Them, K. et al. Sensitivity enhancement in magnetic particle imaging by background subtrac-
tion. IEEE transactions on medical imaging 35, 893–900 (2016).
[39] Straub, M. & Schulz, V. Joint reconstruction of tracer distribution and background in magnetic
particle imaging. IEEE transactions on medical imaging 37, 1192–1203 (2018).
[40] Knopp, T., Them, K., Kaul, M. & Gdaniec, N. Joint reconstruction of non-overlapping magnetic
particle imaging focus-field data. Physics in medicine and biology 60, L15 (2015).
[41] Knopp, T. & Hofmann, M. Online reconstruction of 3D magnetic particle imaging data. Physics
in medicine and biology 61, N257 (2016).
[42] Moreira, M., Dias, P., Cordeiro, M., Santos, G. & Fernandes, J. M. A framework for cerebral
ct perfusion imaging methods comparison. In International Conference Image Analysis and
Recognition, 141–150 (Springer, 2010).
17
